The role of COVID-19 in the development of diabetic nephropathy

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/11022

Full metadata record

DC Field	Value	Language
dc.contributor.author	Dilafruz Khudaybergenova , Dilorom Najmutdinova ,Khilola Mirakhmedova	-
dc.date.accessioned	2024-05-20T11:22:14Z	-
dc.date.available	2024-05-20T11:22:14Z	-
dc.date.issued	2024-05	-
dc.identifier.citation	26th European Congress of Endocrinology 2024	en_US
dc.identifier.issn	1479-6848 (online)	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/11022	-
dc.description.abstract	COVID-19 is the disease caused by a new coronavirus, now called severe acute respiratory syndrome coronavirus. Long COVID is a wide range of new, returning, or ongoing health problems that people experience after being infected with the virus that causes COVID-19. Diabetic nephropathy(DN) is a frequent comorbidity in patients with COVID-19	en_US
dc.language.iso	en	en_US
dc.publisher	bioscientifica	en_US
dc.title	The role of COVID-19 in the development of diabetic nephropathy	en_US
dc.type	Thesis	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
ece2024_abstractbook.pdf		743.43 kB	Adobe PDF	View/Open

DSpace JSPUI